PDS Biotechnology Corp Interest Expense
PDS Biotechnology Corp (PDSB) reported Interest Expense of $1.17 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-15
- PDS Biotechnology Corp interest expense for the quarter ending 2024-03-31 was $1.17M, a 21.50% increase year-over-year.
- PDS Biotechnology Corp interest expense for the quarter ending 2023-12-31 was $1.17M, a 27.81% increase year-over-year.
- PDS Biotechnology Corp interest expense for the quarter ending 2023-09-30 was $1.07M, a 169.02% increase year-over-year.
- PDS Biotechnology Corp interest expense for the quarter ending 2023-06-30 was $995.40K.
- PDS Biotechnology Corp interest expense for fiscal 2023 was $4.21M, a 219.47% increase from fiscal 2022.
- PDS Biotechnology Corp interest expense for fiscal 2022 was $1.32M.
- PDS Biotechnology Corp interest expense for fiscal 2021 was $0.00.
- PDS Biotechnology Corp interest expense for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $1.17M 10-Q · filed 2024-05-15 | $2.35M derived: sum of 2 quarters · filed 2024-05-15 | $3.42M derived: sum of 3 quarters · filed 2024-05-15 | $4.41M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2023-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.24M derived: sum of 2 quarters · filed 2024-03-28 | $3.24M derived: sum of 3 quarters · filed 2024-03-28 | $4.21M 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | $1.07M 10-Q · filed 2023-11-14 | $2.06M derived: sum of 2 quarters · filed 2023-11-14 | $3.03M 10-Q · filed 2023-11-14 | $3.95M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2023-06-30 | $995.40K 10-Q · filed 2023-08-14 | $1.96M 10-Q · filed 2023-08-14 | $2.88M derived: sum of 3 quarters · filed 2024-05-15 | $3.28M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2023-03-31 | $966.85K 10-Q · filed 2024-05-15 | $1.89M derived: sum of 2 quarters · filed 2024-05-15 | $2.28M derived: sum of 3 quarters · filed 2024-05-15 | $2.28M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $919.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.32M derived: sum of 2 quarters · filed 2024-03-28 | $1.32M derived: sum of 3 quarters · filed 2024-03-28 | $1.32M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $397.33K 10-Q · filed 2023-11-14 | $397.33K derived: sum of 2 quarters · filed 2023-11-14 | $397.33K 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-28 | |||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $0.00 derived: sum of 2 quarters · filed 2021-03-18 | $0.00 derived: sum of 3 quarters · filed 2021-03-18 | $0.00 10-K · filed 2021-03-18 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | $32.95K derived: sum of 4 quarters · filed 2021-03-18 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | $32.95K derived: sum of 3 quarters · filed 2021-03-18 | $32.95K derived: sum of 4 quarters · filed 2021-03-18 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-13 | $32.95K derived: sum of 2 quarters · filed 2021-03-18 | $32.95K derived: sum of 3 quarters · filed 2021-03-18 | $32.95K derived: sum of 4 quarters · filed 2021-03-18 | ||||
| 2019-12-31 | $32.95K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $32.95K derived: sum of 2 quarters · filed 2021-03-18 | $32.95K derived: sum of 3 quarters · filed 2021-03-18 | $33.56K 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $606.00 10-Q · filed 2020-11-13 | $1.50K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $606.00 10-Q · filed 2020-08-13 | $1.50K derived: sum of 3 quarters · filed 2020-08-13 | $2.44K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $606.00 10-Q · filed 2020-05-13 | $1.50K derived: sum of 2 quarters · filed 2020-05-13 | $2.44K derived: sum of 3 quarters · filed 2020-05-13 | $3.24K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $890.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $1.83K derived: sum of 2 quarters · filed 2020-03-27 | $2.64K derived: sum of 3 quarters · filed 2020-03-27 | $3.60K 10-K · filed 2020-03-27 | $1.43M 10-K · filed 2019-02-21 | |||
| 2018-09-30 | $942.00 10-Q · filed 2019-11-07 | $0.00 10-Q · filed 2018-11-01 | $1.75K derived: sum of 2 quarters · filed 2019-11-07 | $2.71K 10-Q · filed 2019-11-07 | $1.43M 10-Q · filed 2018-11-01 | $590.85K derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $804.00 10-Q · filed 2019-08-01 | $434.69K 10-Q · filed 2018-08-01 | $1.76K 10-Q · filed 2019-08-01 | $1.43M 10-Q · filed 2018-08-01 | $589.91K derived: sum of 3 quarters · filed 2019-08-01 | $1.18M derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2018-03-31 | $959.00 10-Q · filed 2019-05-14 | $990.56K 10-Q · filed 2018-05-01 | $589.10K derived: sum of 2 quarters · filed 2019-05-14 | $1.18M derived: sum of 3 quarters · filed 2019-05-14 | $1.71M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $588.14K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $1.18M derived: sum of 2 quarters · filed 2019-02-21 | $1.71M derived: sum of 3 quarters · filed 2019-02-21 | $2.18M 10-K · filed 2019-02-21 | ||||
| 2017-09-30 | $592.09K 10-Q · filed 2018-11-01 | $1.12M derived: sum of 2 quarters · filed 2018-11-01 | $1.59M 10-Q · filed 2018-11-01 | $2.08M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $524.77K 10-Q · filed 2018-08-01 | $999.91K 10-Q · filed 2018-08-01 | $1.49M derived: sum of 3 quarters · filed 2018-08-01 | $1.86M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-03-31 | $475.14K 10-Q · filed 2018-05-01 | $961.55K derived: sum of 2 quarters · filed 2018-05-01 | $1.34M derived: sum of 3 quarters · filed 2018-05-01 | $1.50M derived: sum of 4 quarters · filed 2018-05-01 | ||||
| 2016-12-31 | $486.41K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $861.50K derived: sum of 2 quarters · filed 2018-03-01 | $1.02M derived: sum of 3 quarters · filed 2018-03-01 | $1.20M 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $375.09K 10-Q · filed 2017-11-01 | $536.40K derived: sum of 2 quarters · filed 2017-11-01 | $717.26K 10-Q · filed 2017-11-01 | $918.71K derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $161.31K 10-Q · filed 2017-08-01 | $342.17K 10-Q · filed 2017-08-01 | $543.62K derived: sum of 3 quarters · filed 2018-03-01 | $756.64K derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $180.86K 10-Q · filed 2017-05-03 | $382.31K derived: sum of 2 quarters · filed 2018-03-01 | $595.33K derived: sum of 3 quarters · filed 2018-03-01 | $807.20K derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $201.45K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $414.47K derived: sum of 2 quarters · filed 2018-03-01 | $626.33K derived: sum of 3 quarters · filed 2018-03-01 | $816.49K 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $213.02K 10-Q · filed 2016-11-01 | $424.88K derived: sum of 2 quarters · filed 2016-11-01 | $615.05K 10-Q · filed 2016-11-01 | $750.25K derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | $211.86K 10-Q · filed 2016-08-03 | $402.03K 10-Q · filed 2016-08-03 | $537.23K derived: sum of 3 quarters · filed 2017-03-02 | $585.21K derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | $190.16K 10-Q · filed 2016-05-03 | $325.37K derived: sum of 2 quarters · filed 2017-03-02 | $373.34K derived: sum of 3 quarters · filed 2017-03-02 | |||||
| 2014-12-31 | $135.21K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $183.18K derived: sum of 2 quarters · filed 2017-03-02 | $183.18K 10-K · filed 2017-03-02 | |||||
| 2014-09-30 | $47.97K 10-Q · filed 2015-11-06 | $47.97K 10-Q · filed 2015-11-06 | ||||||
| 2013-12-31 | $3.35K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |